Financial Toxicity of Prescription Drugs

Conti, Rena M. PhD

¹Boston University Questrom School of Business, Boston, Massachusetts (R.M.C.)

Disclosures: The author has disclosed no conflicts of interest. The form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-2899.

Corresponding Author: Rena M. Conti, PhD, Boston University Questrom School of Business, 595 Commonwealth Avenue, Boston, MA 02215; e-mail, [email protected].

This article was published at Annals.org on 1 October 2019.

Annals of Internal Medicine - Latest , October 3, 2019. | DOI: 10.7326/M19-2899

In their article, Luo and colleagues examine variation by pharmacy type and ZIP code in the prices of 6 on-patent and 10 off-patent (generic) prescription drugs throughout the United States in 2015. The editorialist discusses the findings and raises concerns about the data the study used.